{"id":14544,"date":"2024-03-07T06:23:55","date_gmt":"2024-03-07T09:23:55","guid":{"rendered":"https:\/\/ocanal.com\/noticias\/corporativas\/c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc\/"},"modified":"2024-03-07T06:23:55","modified_gmt":"2024-03-07T09:23:55","slug":"c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc","status":"publish","type":"post","link":"https:\/\/ocanal.com\/noticias\/corporativas\/c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc\/","title":{"rendered":"C\u2082N Diagnostics, LLC anuncia investimento da Eisai Inc."},"content":{"rendered":"<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.c2n.com&amp;esheet=53905942&amp;newsitemid=20240306011347&amp;lan=pt-BR&amp;anchor=C%26%238322%3BN+Diagnostics%2C+LLC&amp;index=1&amp;md5=18644c3a28bf575781ab2c2796cc5648\" rel=\"nofollow noopener\" shape=\"rect\" target=\"_blank\">C\u2082N Diagnostics, LLC<\/a>, l\u00edder em diagn\u00f3sticos avan\u00e7ados de sa\u00fade cerebral e <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fus.eisai.com%2F&amp;esheet=53905942&amp;newsitemid=20240306011347&amp;lan=pt-BR&amp;anchor=Eisai+Inc.&amp;index=2&amp;md5=bae2e9fc0c994ea54146972c03d2114d\" rel=\"nofollow noopener\" shape=\"rect\" target=\"_blank\">Eisai Inc.<\/a>, uma empresa &#8220;<i>cuidados de sa\u00fade humana<\/i>&#8220;, anunciaram que a Eisai fez um investimento de at\u00e9 US$ 15 milh\u00f5es na C\u2082N.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nOs executivos da C\u2082N dizem que o investimento reflete o desejo comum das duas empresas de expandir e oferecer amplo acesso a seus <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.precivityad.com%2F&amp;esheet=53905942&amp;newsitemid=20240306011347&amp;lan=pt-BR&amp;anchor=testes+Precivity%26%238482%3B&amp;index=3&amp;md5=5ffb0c188a68084e09bb2284ce6fec80\" rel=\"nofollow noopener\" shape=\"rect\" target=\"_blank\">testes Precivity\u2122<\/a>, que s\u00e3o exames de sangue inovadores destinados ao uso em pacientes com defici\u00eancia cognitiva. Estes testes visam ajudar os profissionais de sa\u00fade a determinar a patologia da doen\u00e7a de Alzheimer e ajudar no manuseio m\u00e9dico e nas decis\u00f5es de tratamento.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nAs empresas concordam que o investimento da Eisai ir\u00e1 catalisar os esfor\u00e7os da C\u2082N em expandir a disponibilidade, acessibilidade e uso de testes de biomarcadores sangu\u00edneos com alto desempenho para diagn\u00f3stico precoce da doen\u00e7a de Alzheimer nos EUA.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nO Dr. Joel Braunstein, Diretor Executivo da C\u2082N, disse: &#8220;Apreciamos muito a dedica\u00e7\u00e3o e o rigor que a Eisai trouxe para avaliar o valor e a qualidade de nossas solu\u00e7\u00f5es de diagn\u00f3stico avan\u00e7adas no campo da sa\u00fade cerebral. Com este financiamento, estamos desenvolvendo nossa hist\u00f3ria de atrair investidores da mais alta qualidade, empenhados em mudar a trajet\u00f3ria da doen\u00e7a de Alzheimer por meio da detec\u00e7\u00e3o e tratamento precoces e, em \u00faltima an\u00e1lise, da preven\u00e7\u00e3o. Estamos orgulhosos de ter a lideran\u00e7a da Eisai na \u00e1rea,&agrave;medida que transformamos o padr\u00e3o de gest\u00e3o e atendimento cl\u00ednico para pacientes com doen\u00e7a de Alzheimer. A disponibilidade de biomarcadores sangu\u00edneos que est\u00e3o intimamente correlacionados a medidas de alto padr\u00e3o, como tomografia por emiss\u00e3o de p\u00f3sitrons (PET), ir\u00e1 melhorar a acessibilidade para os pacientes obterem tratamentos farmacol\u00f3gicos seguros e eficazes&agrave;medida que mais estejam dispon\u00edveis.&#8221;<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\n&#8220;O campo de diagn\u00f3sticos sangu\u00edneos altamente precisos est\u00e1 avan\u00e7ando e se expandindo com rapidez&#8221;, disse Keisuke Naito, Diretor Global em Doen\u00e7a de Alzheimer e Vice-Presidente S\u00eanior da Eisai. &#8220;Devido \u00e0s limita\u00e7\u00f5es de custos e capacidade dos testes PET e LCR, a Eisai vem trabalhando para respaldar o crescimento do ecossistema da dem\u00eancia. A disponibilidade de ferramentas de diagn\u00f3stico mais acess\u00edveis e minimamente invasivas ajuda a suportar o amplo acesso para a gest\u00e3o da doen\u00e7a de Alzheimer.&#8221;<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nC<sub>2<\/sub>N e Eisai anunciaram inicialmente em 2022 que estavam trabalhando &#8220;<a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fc2n.com%2Fnews-releases%2Fc2n-and-eisai-collaborate-to-build-awareness-and-real-world-evidence-for-blood-based-assays-for-cognitive-impairment-in-clinical-practice-outside-of-clinical-trial-settings&amp;esheet=53905942&amp;newsitemid=20240306011347&amp;lan=pt-BR&amp;anchor=para+conscientizar+e+desenvolver+evid%26ecirc%3Bncias+do+mundo+real+para+apoiar+o+uso+de+exames+de+sangue+em+pessoas+que+vivem+com+defici%26ecirc%3Bncia+cognitiva+e+que+n%26atilde%3Bo+est%26atilde%3Bo+atualmente+participando+de+um+ensaio+cl%26iacute%3Bnico&amp;index=4&amp;md5=c17e6f03023992fc5279be783c658ba6\" rel=\"nofollow noopener\" shape=\"rect\" target=\"_blank\">para conscientizar e desenvolver evid\u00eancias do mundo real para apoiar o uso de exames de sangue em pessoas que vivem com defici\u00eancia cognitiva e que n\u00e3o est\u00e3o atualmente participando de um ensaio cl\u00ednico<\/a>.&#8221;<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><b>Sobre a C<sub>2<\/sub>N Diagnostics, LLC<\/b><\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><i>A C\u2082N \u00e9 uma empresa de diagn\u00f3sticos especializados com a vis\u00e3o de trazer clareza atrav\u00e9s da inova\u00e7\u00e3o (Clarity Through Innovation\u00ae).<\/i><i>A C\u2082N se esfor\u00e7a para oferecer servi\u00e7os laboratoriais cl\u00ednicos excepcionais e solu\u00e7\u00f5es de diagn\u00f3stico avan\u00e7adas na \u00e1rea da sa\u00fade cerebral.<\/i><i>Os servi\u00e7os e produtos de biomarcadores com base em espectrometria de massa de alta resolu\u00e7\u00e3o da C\u2082N s\u00e3o utilizados em tomadas de decis\u00f5es cl\u00ednicas para aprimorar o atendimento ao paciente, incluindo diagn\u00f3stico e monitoramento de tratamento; maximizar a qualidade e a efici\u00eancia dos ensaios cl\u00ednicos que testam novos tratamentos para a neurodegenera\u00e7\u00e3o; e fornecer ferramentas inovadoras para ajudar os pesquisadores da \u00e1rea da sa\u00fade a entender melhor os novos mecanismos das doen\u00e7as, identificar novos alvos de tratamento e realizar importantes estudos epidemiol\u00f3gicos para melhorar a sa\u00fade p\u00fablica a n\u00edvel mundial.<\/i><i>Os ensaios da C\u2082N foram utilizados em mais de 150 estudos sobre a doen\u00e7a de Alzheimer e outros estudos de pesquisa nos EUA e no mundo. Isto inclui ensaios de tratamento e preven\u00e7\u00e3o de refer\u00eancia envolvendo terapias modificadoras da doen\u00e7a (DMTs) que est\u00e3o transformando a trajet\u00f3ria da doen\u00e7a de Alzheimer.<\/i><i>A C\u2082N mant\u00e9m coopera\u00e7\u00f5es cont\u00ednuas com empresas farmac\u00eauticas e de biotecnologia multinacionais, institui\u00e7\u00f5es acad\u00eamicas l\u00edderes, Instituto Nacional do Envelhecimento, Alzheimer&#8217;s Association, bem como outras organiza\u00e7\u00f5es sem fins lucrativos e cons\u00f3rcios. Mais de 15.000 medidas de biomarcadores referentes ao Precivity\u2122 foram relatadas atrav\u00e9s de publica\u00e7\u00f5es revisadas por pares, com muitos outros manuscritos atualmente em revis\u00e3o.<\/i><\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><i>A empresa reconhece o apoio generoso do Instituto Nacional do Envelhecimento, GHR Foundation, Alzheimer&#8217;s Drug Discovery Foundation, BrightFocus Foundation e Alzheimer&#8217;s Association. Para mais informa\u00e7\u00e3o, acesse<\/i><i><a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.C2N.com&amp;esheet=53905942&amp;newsitemid=20240306011347&amp;lan=pt-BR&amp;anchor=www.C2N.com&amp;index=5&amp;md5=3e2e8e013c550cc1c75a7b46a38ffaf4\" rel=\"nofollow noopener\" shape=\"rect\" target=\"_blank\">www.C2N.com<\/a>.<\/i><\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nO texto no idioma original deste an\u00fancio \u00e9 a vers\u00e3o oficial autorizada. As tradu\u00e7\u00f5es s\u00e3o fornecidas apenas como uma facilidade e devem se referir ao texto no idioma original, que \u00e9 a \u00fanica vers\u00e3o do texto que tem efeito legal.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20240306011347r1&amp;sid=brdno&amp;distro=ftp\"><span class=\"bwct31415\"><\/span><\/p>\n<p id=\"mmgallerylink\" xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><span id=\"mmgallerylink-phrase\">Ver a vers\u00e3o original em businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20240306011347\/pt\/\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.businesswire.com\/news\/home\/20240306011347\/pt\/<\/a><\/span><\/p>\n<p><b>Contato:<\/b><\/p>\n<p>\nCONTATO DA EMPRESA:\n<\/p>\n<p>Joni Henderson\n<\/p>\n<p><a href=\"mailto:JHenderson@c2n.com\" rel=\"nofollow\" shape=\"rect\">JHenderson@c2n.com<br \/>\n<\/a><\/p>\n<p>314-464-0009\n<\/p>\n<\/p>\n<p>CONTATO DE M\u00cdDIA:\n<\/p>\n<p>Adam Shapiro\n<\/p>\n<p><a href=\"mailto:Adam.Shapiro@ASPR.bz\" rel=\"nofollow\" shape=\"rect\">Adam.Shapiro@ASPR.bz<br \/>\n<\/a><\/p>\n<p>202-427-3603<\/p>\n<p><strong>Fonte: <\/strong><a href='http:\/\/www.businesswire.com\/portal\/site\/home\/' target='_blank' rel=\"noopener\">BUSINESS WIRE<\/a><img src='https:\/\/api.dino.com.br\/v2\/news\/tr\/302131?partnerId=3197' alt=\"\" style=\"border:0px;width:1px;height:1px;\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>C\u2082N Diagnostics, LLC, l\u00edder em diagn\u00f3sticos avan\u00e7ados de sa\u00fade cerebral e Eisai Inc., uma empresa &#8220;cuidados de sa\u00fade humana&#8220;, anunciaram que a Eisai fez um investimento de at\u00e9 US$ 15 milh\u00f5es na C\u2082N. Os executivos da C\u2082N dizem que o investimento reflete o desejo comum das duas empresas de expandir e oferecer amplo acesso a [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-14544","post","type-post","status-publish","format-standard","hentry","category-noticias"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>C\u2082N Diagnostics, LLC anuncia investimento da Eisai Inc. - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ocanal.com\/noticias\/corporativas\/c\u2082n-diagnostics-llc-anuncia-investimento-da-eisai-inc\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u2082N Diagnostics, LLC anuncia investimento da Eisai Inc. - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\" \/>\n<meta property=\"og:description\" content=\"C\u2082N Diagnostics, LLC, l\u00edder em diagn\u00f3sticos avan\u00e7ados de sa\u00fade cerebral e Eisai Inc., uma empresa &#8220;cuidados de sa\u00fade humana&#8220;, anunciaram que a Eisai fez um investimento de at\u00e9 US$ 15 milh\u00f5es na C\u2082N. Os executivos da C\u2082N dizem que o investimento reflete o desejo comum das duas empresas de expandir e oferecer amplo acesso a [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ocanal.com\/noticias\/corporativas\/c\u2082n-diagnostics-llc-anuncia-investimento-da-eisai-inc\/\" \/>\n<meta property=\"og:site_name\" content=\"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-07T09:23:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20240306011347r1&amp;sid=brdno&amp;distro=ftp\" \/>\n<meta name=\"author\" content=\"DINO\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"DINO\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc\\\/\"},\"author\":{\"name\":\"DINO\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\"},\"headline\":\"C\u2082N Diagnostics, LLC anuncia investimento da Eisai Inc.\",\"datePublished\":\"2024-03-07T09:23:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc\\\/\"},\"wordCount\":870,\"image\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20240306011347r1&amp;sid=brdno&amp;distro=ftp\",\"articleSection\":[\"Not\u00edcias Corporativas\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc\\\/\",\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc\\\/\",\"name\":\"C\u2082N Diagnostics, LLC anuncia investimento da Eisai Inc. - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20240306011347r1&amp;sid=brdno&amp;distro=ftp\",\"datePublished\":\"2024-03-07T09:23:55+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20240306011347r1&amp;sid=brdno&amp;distro=ftp\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20240306011347r1&amp;sid=brdno&amp;distro=ftp\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u2082N Diagnostics, LLC anuncia investimento da Eisai Inc.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#website\",\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/\",\"name\":\"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\",\"description\":\"Tudo sobre o mercado empresarial, comunicados e neg\u00f3cios\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\",\"name\":\"DINO\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"caption\":\"DINO\"},\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/author\\\/dino\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"C\u2082N Diagnostics, LLC anuncia investimento da Eisai Inc. - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ocanal.com\/noticias\/corporativas\/c\u2082n-diagnostics-llc-anuncia-investimento-da-eisai-inc\/","og_locale":"pt_BR","og_type":"article","og_title":"C\u2082N Diagnostics, LLC anuncia investimento da Eisai Inc. - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","og_description":"C\u2082N Diagnostics, LLC, l\u00edder em diagn\u00f3sticos avan\u00e7ados de sa\u00fade cerebral e Eisai Inc., uma empresa &#8220;cuidados de sa\u00fade humana&#8220;, anunciaram que a Eisai fez um investimento de at\u00e9 US$ 15 milh\u00f5es na C\u2082N. Os executivos da C\u2082N dizem que o investimento reflete o desejo comum das duas empresas de expandir e oferecer amplo acesso a [&hellip;]","og_url":"https:\/\/ocanal.com\/noticias\/corporativas\/c\u2082n-diagnostics-llc-anuncia-investimento-da-eisai-inc\/","og_site_name":"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","article_published_time":"2024-03-07T09:23:55+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20240306011347r1&amp;sid=brdno&amp;distro=ftp","type":"","width":"","height":""}],"author":"DINO","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"DINO","Est. tempo de leitura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc\/#article","isPartOf":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc\/"},"author":{"name":"DINO","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff"},"headline":"C\u2082N Diagnostics, LLC anuncia investimento da Eisai Inc.","datePublished":"2024-03-07T09:23:55+00:00","mainEntityOfPage":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc\/"},"wordCount":870,"image":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20240306011347r1&amp;sid=brdno&amp;distro=ftp","articleSection":["Not\u00edcias Corporativas"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc\/","url":"https:\/\/ocanal.com\/noticias\/corporativas\/c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc\/","name":"C\u2082N Diagnostics, LLC anuncia investimento da Eisai Inc. - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","isPartOf":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc\/#primaryimage"},"image":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20240306011347r1&amp;sid=brdno&amp;distro=ftp","datePublished":"2024-03-07T09:23:55+00:00","author":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff"},"breadcrumb":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ocanal.com\/noticias\/corporativas\/c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20240306011347r1&amp;sid=brdno&amp;distro=ftp","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20240306011347r1&amp;sid=brdno&amp;distro=ftp"},{"@type":"BreadcrumbList","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/c%e2%82%82n-diagnostics-llc-anuncia-investimento-da-eisai-inc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/ocanal.com\/noticias\/corporativas\/"},{"@type":"ListItem","position":2,"name":"C\u2082N Diagnostics, LLC anuncia investimento da Eisai Inc."}]},{"@type":"WebSite","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#website","url":"https:\/\/ocanal.com\/noticias\/corporativas\/","name":"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","description":"Tudo sobre o mercado empresarial, comunicados e neg\u00f3cios","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ocanal.com\/noticias\/corporativas\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff","name":"DINO","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","caption":"DINO"},"url":"https:\/\/ocanal.com\/noticias\/corporativas\/author\/dino\/"}]}},"_links":{"self":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts\/14544","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/comments?post=14544"}],"version-history":[{"count":0,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts\/14544\/revisions"}],"wp:attachment":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/media?parent=14544"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/categories?post=14544"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/tags?post=14544"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}